抗抑郁药5-羟色胺再摄取抑制强度与缺血风险:队列研究
该队列研究基于英国临床实践研究数据链,纳入1995至2014年间新使用SSRI或第三代抗抑郁药的成人,采用嵌套病例对照设计,比较强效与弱效5-羟色胺再摄取抑制剂使用者的缺血性卒中与心肌梗死发生率。结果显示强效抑制剂与缺血性卒中率轻度降低相关(RR 0.88,95%CI 0.80-0.97),心肌梗死率无差异(RR 1.00,95%CI 0.87-1.15)。
要点
- 强效5-羟色胺再摄取抑制剂与缺血性卒中率轻度降低相关。
- 强效与弱效抑制剂的心肌梗死发生率相似。
- 该关联在部分敏感性分析中效应量较小,需谨慎解读。
核心结论
- 抗抑郁药强效抑制5-羟色胺再摄取可能与缺血性卒中率轻度降低相关。
研究设计与样本
- 基于英国临床实践研究数据链的队列研究,纳入1995至2014年间新使用SSRI或第三代抗抑郁药的≥18岁成人。
- 队列共938,388例新使用者(SSRI 868,755例,第三代抗抑郁药69,633例),入组平均年龄46岁,女性占64%。
- 采用嵌套病例对照方法,随访期间识别缺血性卒中15,860例和心肌梗死8,626例,分别匹配473,712和258,022名对照。
主要发现
- 与当前使用弱效5-羟色胺再摄取抑制剂相比,当前使用强效抑制剂的缺血性卒中发生率比为0.88(95%CI 0.80-0.97)。
- 强效与弱效抑制剂的心肌梗死发生率相似(RR 1.00,95%CI 0.87-1.15)。
- 强效抑制剂对缺血性卒中的效应量在部分敏感性分析中较小。
临床怎么用
- 对于有缺血性卒中风险的抑郁患者,选择强效5-羟色胺再摄取抑制剂可能具有轻微获益。
- 该研究未显示强效抑制剂增加心肌梗死风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether use of antidepressants with strong inhibition of serotonin reuptake is associated with a decreased incidence of ischemic stroke and myocardial infarction (MI). METHODS: We conducted a cohort study using the UK Clinical Practice Research Datalink and considering new users of selective serotonin reuptake inhibitors (SSRIs) or third-generation antidepressants who were ≥18 years of age between 1995 and 2014. Using a nested case-control approach, we matched each case of a first ischemic stroke or MI identified during follow-up with up to 30 controls on age, sex, calendar time, and duration of follow-up. We estimated incidence rate ratios (RRs) and 95% confidence intervals (CIs) of each outcome associated with current use of strong compared with weak inhibitors of serotonin reuptake using conditional logistic regression. RESULTS: The cohort included 938,388 incident users of SSRIs (n = 868,755) or third-generation antidepressants (n = 69,633). Mean age at cohort entry was 46 years (64% women). During follow-up, 15,860 cases of ischemic stroke and 8,626 cases of MI were identified and matched to 473,712 and 258,022 controls, respectively. Compared with current use of weak inhibitors of serotonin reuptake, current use of strong inhibitors was associated with a decreased rate of ischemic stroke (RR 0.88, 95% CI 0.80-0.97), but the effect size was smaller in some sensitivity analyses. The rate of MI was similar between strong and weak inhibitors (RR 1.00, 95% CI 0.87-1.15). CONCLUSION: Our large population-based study suggests that antidepressants strongly inhibiting serotonin reuptake may be associated with a small decrease in the rate of ischemic stroke.
引用
- Douros A, Dell'Aniello S, Dehghan G, et al. Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study. Neurology. 2019. PMID: 31391245. doi:10.1212/WNL.0000000000008060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。